Synopsis3-Benzylidene Camphor is currently authorised for use in cosmetic products as a UV filter. The global 3-Benzylidene Camphor market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the foreca.....
SynopsisEthylenediaminetetraacetic acid (EDTA) is an anticoagulant, majorly used in preventing clotting of blood. The global EDTA Dipotassium Dihydrate market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of.....
SynopsisEchinatin is a licorice extract that displays antioxidant properties and anti-inflammatory activities. The global Echinatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the foreca.....
SynopsisWogonoside, a flavanoid, is known for its anti-inflammatory properties. Wogonoside may have therapeutic potential for use in diseases which involve the development of inflammation and angiogenesis through its inhibition of LPS-induced angiogenesis. The g.....
SynopsisTravoprost is a potent FP receptor agonist that finds clinical use as an ocular hypotensive agent for the treatment of glaucoma. The global Travoprost market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a .....
SynopsisTravoprost is a potent and selective FP prostaglandin receptor agonist used for the treatment of glaucoma. The global Travoprost Reagent market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % duri.....
SynopsisCloprostenol is used in veterinary medicine as a luteolytic agent for the induction of estrus and the treatment of reproductive disorders in cattle, swine, and horses. The global Cloprostenol Sodium Salt market was valued at US$ million in 2023 and is a.....
SynopsisCloprostenol sodium salt hydrate is a potent FP prostanoid receptor agonist which is 2- to 3-fold more potent than fluprostenol, although less selective. The global Cloprostenol Sodium Salt Reagent market was valued at US$ million in 2023 and is anticipa.....
SynopsisGliclazide is an oral hypoglycemic and is classified as a sulfonylurea. The global Gliclazide market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. Nor.....
SynopsisGliclazide is a sulfonylurea and an inhibitor of pancreatic β-cell ATP-sensitive potassium (KATP) channels. The global Gliclazide Reagent market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % dur.....
